Angelo Zanniti/LinkedIn
Jun 15, 2026, 13:05
Angelo Zanniti: Back from EHA 2026 Congress
Angelo Zanniti, Medical Biotechnologist at CEINGE Official Profile, shared a post on LinkedIn:
“Back from an inspiring few days at the EHA 2026 Congress in Stockholm.
It was a great opportunity to connect with colleagues, share experiences, and discover the latest advances in hematology and molecular diagnostics.
Conferences like these remind us how quickly our field is evolving and how important collaboration is in driving innovation and improving patient care.
Grateful for the experience and looking forward to putting new ideas into practice.”
Stay updated with Hemostasis Today.
-
Jun 15, 2026, 12:56Chiara Pirillo: Building Global Connections at EHA 2026
-
Jun 15, 2026, 12:50Marina Planas: MRD and Molecular Monitoring Take Center Stage at EHA 2026
-
Jun 15, 2026, 12:46Moonmoon Kazi: Climb Bio Presents Phase 1b ITP Trial Data at EHA 2026
-
Jun 15, 2026, 12:44Wolfgang Miesbach: Base Editing and the Future of Sickle Cell Disease Therapy
-
Jun 15, 2026, 12:31Chandrashekhar Athare: EHA 2026 Concludes with Lasting Impact and New Collaborations
-
Jun 15, 2026, 10:49Aurelio Maggio: How Is The Treatment Landscape Of Thrombotic Thrombocytopenic Purpura Evolving?
-
Jun 15, 2026, 10:49Marek Mráz: A Landmark EHA 2026 for Our Lab
-
Jun 15, 2026, 10:32Magnus Ek: Operational Excellence in Delivering Seamless Access for 17,000 Delegates at EHA 2026 Congress
-
Jun 15, 2026, 10:15Carol Bewick: Why the Global Community Makes EHA 2026 Unforgettable